Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Talbot

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 2, 2011
Reasons given by patients for participating, or not, in Phase 1 cancer trialsS Catt, C Langridge, L Fallowfield, et al.
Cancer Research|July 14, 1998
Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitroA V Patterson, D C Talbot, I J Stratford, et al.
Journal of Clinical Pathology|February 1, 1994
Signet-ring cell lymphoma of bone marrowD C Talbot, J H Davies, K A Maclennan, et al.
Journal of the National Cancer Institute|January 1, 1977
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissuesJ A Straw, D C Talbot, G A Taylor, et al.
The British Journal of Dermatology|April 1, 1992
Chylous ascites in Kaposi's sarcoma: a case reportK M Fife, D C Talbot, P Mortimer, et al.
Journal of Medical Microbiology|December 5, 1998
Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureusK J Towner, D C Talbot, R Curran, et al.
Hospital Medicine (London, England : 1998)|November 3, 1998
Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemiaD C Talbot, A Montes, W L Teh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancerP A Ellis, D C Talbot, K Priest, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 1999
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factorP A Philip, D Rea, K Mitchell, et al.
British Journal of Cancer|June 1, 1995
A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancerP A Ellis, D C Talbot, M C Nicolson, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|April 2, 2011
Reasons given by patients for participating, or not, in Phase 1 cancer trialsS Catt, C Langridge, L Fallowfield, et al.
Cancer Research|July 14, 1998
Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitroA V Patterson, D C Talbot, I J Stratford, et al.
Journal of Clinical Pathology|February 1, 1994
Signet-ring cell lymphoma of bone marrowD C Talbot, J H Davies, K A Maclennan, et al.
Journal of the National Cancer Institute|January 1, 1977
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissuesJ A Straw, D C Talbot, G A Taylor, et al.
The British Journal of Dermatology|April 1, 1992
Chylous ascites in Kaposi's sarcoma: a case reportK M Fife, D C Talbot, P Mortimer, et al.
Journal of Medical Microbiology|December 5, 1998
Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureusK J Towner, D C Talbot, R Curran, et al.
Hospital Medicine (London, England : 1998)|November 3, 1998
Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemiaD C Talbot, A Montes, W L Teh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Dose intensification of carboplatin and etoposide as first-line combination chemotherapy in small cell lung cancerP A Ellis, D C Talbot, K Priest, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 1999
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factorP A Philip, D Rea, K Mitchell, et al.
British Journal of Cancer|June 1, 1995
A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancerP A Ellis, D C Talbot, M C Nicolson, et al.
Pageof 7